Caroline Erickson - Concepedia

Concepedia

Author

Caroline Erickson

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

C Erickson, Caroline E. Erickson, Caroline Erickson

26

Publications

1.1K

Citations

12

H-Index

40

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center University of Washington Fred Hutch Cancer Center Cornell University Rutgers, The State University of New Jersey

CE

About

Caroline Erickson is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	745
2	Cell Biology	4	4	426
3	Immunology	3	3	319
4	Cellular Therapies	2	2	52
5	Allergy	1	1	32

Caroline Erickson

×

12

Publications

1.1K

Citations

12

H-Index

	Year	Citations
Pharmacologic modulation of RNA splicing enhances anti-tumor immunity Sydney X. Lu, Emma De Neef, James D. Thomas, Cell ImmunologyRna SplicingTumor ImmunitySplicing VariantMedicine	2021	267
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms Benjamin H. Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, Nature Medicine Signal TransductionSignaling PathwayHistiocytic NeoplasmsMedicineReceptor Tyrosine Kinase	2019	219
Developing human pluripotent stem cell-based cerebral organoids with a controllable microglia ratio for modeling brain development and pathology Ranjie Xu, Andrew J. Boreland, Xiaoxi Li, Stem Cell Reports	2021	204
Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition Daichi Inoue, Jacob T. Polaski, Justin Taylor, Nature Genetics Tumor HeterogeneityMedicineDiverse Cancer PredispositionPathologyCancer Genomics	2021	105
Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia Eric Wang, Jose Mario Bello Pineda, Won Jun Kim, Cancer Cell	2022	74
Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells Khrystyna North, Salima Benbarche, Bo Liu, Nature Biotechnology Rna ProcessingMedicineCancer Cell BiologyCancer GenomicsCancer Genetics	2022	59
Mutant SF3B1 promotes AKT- and NF-κB–driven mammary tumorigenesis Bo Liu, Zhaoqi Liu, Sisi Chen, Journal of Clinical Investigation Mutant Sf3b1Cancer BiologySplicing VariantMammary Gland DevelopmentTumor Biology	2020	43
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation Sisi Chen, Rahul S. Vedula, Antonio Cuevas-Navarro, Cancer Discovery	2022	36
Immunity to lymphoid tumors in syngeneic mice by immunization with mitomycin C-treated cells. Eli Benjamini, Sherman Fong, Caroline Erickson, PubMed Cell TherapyAdaptive Immune SystemImmunologyImmune RegulationPathology	1977	32
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia Katherine Knorr, Jahan Rahman, Caroline Erickson, Nature Cancer	2023	21

Page 1